azides has been researched along with Psoriasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 4 (57.14) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benes, P; Benz, RE; Färber, L; Langendorf, Y; Schopf, RE | 1 |
| Anderson, WB; Evain-Brion, D; Gerbaud, P; Lohmann, SM; Raynaud, F; Tournier, S | 2 |
| Anderson, WB; Bouloc, A; Evain-Brion, D; Gerbaud, P; Gorin, I; Raynaud, F | 1 |
| Anderson, WB; Evain-Brion, D; Gerbaud, P; Gorin, I; Liapi, C; Marciano, D; Raynaud, F | 1 |
| Lindgren, S; Stendahl, O | 1 |
| Anderson, W; Brion, DE; Laurent, P; Leduc, B; Plet, A; Raynaud, F | 1 |
1 trial(s) available for azides and Psoriasis
| Article | Year |
|---|---|
A highly decreased binding of cyclic adenosine monophosphate to protein kinase A in erythrocyte membranes is specific for active psoriasis.
Topics: Administration, Topical; Adolescent; Adult; Affinity Labels; Aged; Anthralin; Anti-Inflammatory Agents; Azides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclosporine; Dermatologic Agents; Erythrocyte Membrane; Etretinate; Female; Humans; Keratolytic Agents; Male; Middle Aged; Protein Binding; Psoriasis; Retinoids; Severity of Illness Index | 2002 |
6 other study(ies) available for azides and Psoriasis
| Article | Year |
|---|---|
Post-translational abnormality of the type II cyclic AMP-dependent protein kinase in psoriasis: modulation by retinoic acid.
Topics: Autoradiography; Azides; Binding Sites; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Densitometry; Fibroblasts; Humans; Immunoblotting; Phosphorylation; Precipitin Tests; Protein Processing, Post-Translational; Psoriasis; Tretinoin | 1995 |
Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit.
Topics: Acitretin; Affinity Labels; Azides; Cell Separation; Cyclic AMP; Dose-Response Relationship, Drug; Erythrocyte Membrane; Erythrocytes; Humans; Protein Kinases; Psoriasis; Time Factors | 1993 |
Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts.
Topics: Affinity Labels; Autoradiography; Azides; Blotting, Western; Cell Fractionation; Chromatography; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Type II; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; Humans; Phosphorus Radioisotopes; Protein Binding; Psoriasis; Skin; Time Factors; Tretinoin; Tritium | 1996 |
Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis.
Topics: Animals; Antioxidants; Azides; Binding Sites; Cattle; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Fibroblasts; Free Radical Scavengers; Free Radicals; Humans; Hydrogen Peroxide; In Vitro Techniques; Oxidation-Reduction; Psoriasis; Reactive Oxygen Species | 1997 |
Function of granulocytes with deficient myeloperoxidase-mediated iodination in a patient with generalized pustular psoriasis.
Topics: Azides; Blood Bactericidal Activity; Candida albicans; Escherichia coli; Granulocytes; Hexosephosphates; Humans; Iodine; Leukocytes; Male; Middle Aged; Peroxidase; Peroxidases; Phagocytosis; Psoriasis | 1976 |
Deficiency of cyclic AMP-dependent protein kinases in human psoriasis.
Topics: Affinity Labels; Azides; Cells, Cultured; Chromatography, DEAE-Cellulose; Cyclic AMP; Cytosol; Erythrocyte Membrane; Fibroblasts; Humans; Protein Kinases; Psoriasis | 1986 |